Future Directions for Type 2 Inflammation Management
Reynold A. Panettieri Jr., MD, examines the application of biologic therapies in the treatment of respiratory conditions.
Strategies to Manage Type 2 Inflammation in Respiratory Diseases
A key opinion leader explores therapeutic approaches targeting inflammation to alleviate symptoms in COPD and asthma patients.
Biomarkers as Tools in Management of Type 2 Inflammation
An expert in COPD delves into biomarkers indicative of type 2 inflammation and recommends diagnostic tests for assessing inflammation in COPD patients.
Impact of Exacerbations in Type 2 Inflammatory Respiratory Diseases
Reynold A. Panettieri Jr., MD, elaborates on the risks of lung damage resulting from exacerbations, with a focus on the role of type 2 inflammation in triggering these events.
Linking Type 2 Inflammation to Asthma and COPD
A key opinion leader examines the etiology of asthma and potential risk factors for COPD development, emphasizing the role of environmental exposures.
Navigating the Challenges of Respiratory Diseases
Reynold A. Panettieri Jr., MD, explores the impact of COPD and asthma on patients' quality of life, highlighting exercise limitations and sleep disturbances.
